ARTICLE | Company News
AbCheck, Daiichi Sankyo deal
February 25, 2013 8:00 AM UTC
AbCheck will use its AbSieve phage and yeast display technologies to discover antibodies against an undisclosed number of cancer targets from Daiichi's U3 Pharma GmbH affiliate. U3 will have rights to...